![Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup](https://www.frontiersin.org/files/Articles/508566/fonc-10-00008-HTML/image_m/fonc-10-00008-t002.jpg)
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
![Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients - Aasebø - 2019 - Cancer Medicine - Wiley Online Library Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients - Aasebø - 2019 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/fc52f631-aafe-42c8-b1c7-99868414bdff/cam42205-fig-0001-m.jpg)
Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients - Aasebø - 2019 - Cancer Medicine - Wiley Online Library
![Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup](https://www.frontiersin.org/files/Articles/508566/fonc-10-00008-HTML/image_m/fonc-10-00008-g001.jpg)
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
![EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine | Scientific Reports EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-02181-7/MediaObjects/41598_2021_2181_Fig8_HTML.png)
EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine | Scientific Reports
![EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine | Scientific Reports EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-02181-7/MediaObjects/41598_2021_2181_Fig1_HTML.png)
EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine | Scientific Reports
![EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine | Scientific Reports EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-02181-7/MediaObjects/41598_2021_2181_Fig5_HTML.png)
EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine | Scientific Reports
Folk och Kultur - Vi gratulerar Jojje Olsson till Selanderpriset! Eskilstuna-Kurirens stiftelse delade för första gången ut Selanderpriset för journalistiskt civilkurage under Folk och Kultur. Priset på 100 000 kronor som tilldelas
![FMSF on X: "Vid 2023 års representantskap den 12-14 maj delades guldnålen ut till Edvard Selander Patrignani. Studentförbundets finaste utmärkelse delas ut till tidigare förbundsordföranden, förbundssekreterare, viceordföranden som också utfört ... FMSF on X: "Vid 2023 års representantskap den 12-14 maj delades guldnålen ut till Edvard Selander Patrignani. Studentförbundets finaste utmärkelse delas ut till tidigare förbundsordföranden, förbundssekreterare, viceordföranden som också utfört ...](https://pbs.twimg.com/media/Fy_xijJWIAADl4C.jpg:large)